NSEDisclosure of material issue2 Sept 2026 · 2 Sept 2026, 04:57 pm

Disclosure of material issue

Blue Star Limited · BLUESTARCO

✦ AI SummaryDivestiture

Blue Star Limited has informed about the completion of the sale and transfer of its MedTech business to Cyrix Healthcare Private Limited, effective September 1, 2026.

Analysis Scores

Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Blue Star Limited has informed regarding Update on completion of sale and transfer of MedTech business of Blue Star Engineering & Electronics Limited, a wholly owned subsidiary of the Company

Attachments (1)

📄

BLUESTARCO_02092026165704_Stock_Exchange-Update_on_MEdTech_Transfer.pdf

pdf

Download →
View document text
Blue Star Limited Band Box House, 4th Floor, 254 D, Dr Annie Besant Road, Worli, Mumbai 400 030, India. T : +91 22 6654 4000 E : secretarialdesk@bluestarindia.com www.bluestarindia.com September 2, 2026 BSE Limited National Stock Exchange of India Ltd Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Bandra (East), Mumbai – 400 001 Mumbai – 400 051 BSE Scrip Code: 500067 NSE Symbol: BLUESTARCO Dear Sir/Madam, Sub.: Update on completion of sale and transfer of MedTech business of Blue Star Engineering & Electronics Limited, a wholly owned subsidiary of the Company We refer to our letter dated August 14, 2026 (enclosed), wherein we had intimated about the execution of a Business Transfer Agreement (‘BTA’) by Blue Star Engineering & Electronics Limited (‘Blue Star E&E’), a wholly owned subsidiary of the Company, with Cyrix Healthcare Private Limited (‘Cyrix’) for the sale and transfer of Blue Star E&E’s MedTech business, comprising the business of providing high-end medical diagnostic equipment and services, as a going concern on a slump sale basis. In connection therewith, we hereby inform you that Medtech business of Blue Star E&E has been transferred to Cyrix effective September 1, 2026. The confirmation in this regard was acknowledged by Cyrix yesterday at 11.30 p.m. The consideration is payable in tranches, subject to adjustments, if any, in accordance with the terms of the BTA, with the final tranche payable on March 31, 2027. This is for your information and record. The above information is also being placed on the website of the Company at www.bluestarindia.com Registered Office: Kasturi Buildings, Mohan T Advani Chowk, Jamshedji Tata Road, Mumbai 400 020, India. T: +91 22 6665 4000 CIN: L 28920MH1949PLC 006870 Blue Star Limited Band Box House, 4th Floor, 254 D, Dr Annie Besant Road, Worli, Mumbai 400 030, India. T : +91 22 6654 4000 E : secretarialdesk@bluestarindia.com www.bluestarindia.com Thanking you, Yours faithfully, For Blue Star Limited Rajesh Parte Company Secretary & Compliance Officer Membership No.: A10700 Encl: a/a Registered Office: Kasturi Buildings, Mohan T Advani Chowk, Jamshedji Tata Road, Mumbai 400 020, India. T: +91 22 6665 4000 CIN: L 28920MH1949PLC 006870 Blue Star Limited Band Box House, 4th Floor, 254 D, Dr Annie Besant Road, Worli, Mumbai 400 030, India. T : +91 22 6654 4000 E : secretarialdesk@bluestarindia.com www.bluestarindia.com August 14, 2026 BSE Limited National Stock Exchange of India Ltd Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Bandra (East), Mumbai 400 001 Mumbai 400 051 BSE Scrip Code: 500067 NSE Symbol: BLUESTARCO Dear Sir/Madam, Sub.: Intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Execution of Business Transfer Agreement by Blue Star Engineering & Electronics Limited, a wholly owned subsidiary of the Company. In compliance with Regulation 30 read with Para A of Part A of Schedule III of the Listing Regulations, we hereby inform you that the Board of Directors of the Blue Star Engineering at its meeting held today i.e. Friday, August 14, 2026, has, inter alia, executed a Business for the sale and providing high- end medical diagnostic equipment and services, as going concern on a slump sale basis, on such terms and conditions as detailed in the BTA. The meeting of Blue Star E&E commenced at 6:15 p.m. and concluded at 6:45 p.m. The details as required under Para A of Part A of Schedule III of the Listing Regulations and the SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated The above information is also being placed on the website of the Company at www.bluestarindia.com Kindly take the same on record. Thanking you, Registered Office: Kasturi Buildings, Mohan T Advani Chowk, Jamshedji Tata Road, Mumbai 400 020, India. T: +91 22 6665 4000 CIN: L 28920MH1949PLC 006870 Blue Star Limited Band Box House, 4th Floor, 254 D, Dr Annie Besant Road, Worli, Mumbai 400 030, India. T : +91 22 6654 4000 E : secretarialdesk@bluestarindia.com www.bluestarindia.com Yours faithfully, For Blue Star Limited Rajesh Parte Company Secretary & Compliance Officer Membership No.: A10700 Encl: a/a Registered Office: Kasturi Buildings, Mohan T Advani Chowk, Jamshedji Tata Road, Mumbai 400 020, India. T: +91 22 6665 4000 CIN: L 28920MH1949PLC 006870 Blue Star Limited Band Box House, 4th Floor, 254 D, Dr Annie Besant Road, Worli, Mumbai 400 030, India. T : +91 22 6654 4000 E : secretarialdesk@bluestarindia.com www.bluestarindia.com ANNEXURE - I Details as required under the Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 Particulars Description 1. The amount and percentage The MedTech division of Blue Star E&E of the turnover or revenue or generated a total income of Rs 42.13 crores income and net worth during the financial year ended March 31, 2026, contributed by such unit or representing approximately 0.33% of the division or undertaking or consolidated income from operations subsidiary or associate for the said year. company of the listed entity during the last financial year; As the MedTech division forms an integral part of the Blue Star E&E its net worth is not maintained or reported separately. As per the audited consolidated financial statements of the Company for the year ended March 31, 2026, Blue Star E&E MedTech division net worth is approximately Rs 7.11 crores as on March 31, 2026, constituting around 0.21% 2. Date on which the August 14, 2026 agreement for sale has been entered into; 3. The expected date of Slump Sale of MedTech division of Blue Star E&E completion of sale/disposal; is proposed to be completed by March 31, 2027, subject to satisfactory fulfilment of the conditions precedent, including obtaining all requisite approvals and completion of such procedures as may be required, in accordance with the terms of the BTA. 4. Consideration received from Upto Rs 40,00,00,000 (Rupees Forty Crores), as such sale/disposal; per the terms of the BTA. 5. brief details of buyers and Cyrix Healthcare Private Limited (Cyrix) is a whether any of the buyers leading, pan-India Total MedTech Management belong to the promoter/ Solutions provider with over 22 years of industry Registered Office: Kasturi Buildings, Mohan T Advani Chowk, Jamshedji Tata Road, Mumbai 400 020, India. T: +91 22 6665 4000 CIN: L 28920MH1949PLC 006870 Blue Star Limited Band Box House, 4th Floor, 254 D, Dr Annie Besant Road, Worli, Mumbai 400 030, India. T : +91 22 6654 4000 E : secretarialdesk@bluestarindia.com www.bluestarindia.com promoter group/group experience. companies. If yes, details thereof; Cyrix is not a part of the Promoter or Promoter Group of the Company. 6. whether the transaction This transaction does not fall within the ambit of would fall within related related party transactions. party transactions? If yes, whether the same is done at 7. Whether the sale, lease or Yes, the transaction is outside the scope of the disposal of the undertaking Scheme of Arrangement. is outside Scheme of Arrangement? If yes, details The provisions of Regulation 37A of the SEBI of the same including Listing Regulations are not applicable to this compliance with regulation transaction. 37A of Listing Regulations; Additional disclosure in case of a Slump Sale 8. Name of the entity(is) Please refer to the details specified in point nos. forming part of the slump (1) and (5) above. sale, details in brief such as, size, turnover etc. 9. Whether the transaction This transaction does not fall within the ambit of would fall within related related party transactions. party transactions? If yes, whether the same is done at 10. Area of business of the Seller: entity(ices); Blue Star Engineering & Electronics Limited (Blue Star E&E), a wholly-owned subsidiary of Blue Star Limited, is a leading [Showing first 8,000 characters — download PDF for full document]